Ultra-high performance liquid chromatography (UPLC) system for a Thermo Scientific Q-Exactive (QE) to support method development for economic adulteration

The U.S. Food and Drug Administration (FDA) is conducting market research to procure an ultra-high performance liquid chromatography (UPLC) system, specifically a Thermo Scientific Q-Exactive (QE), for its Office of Laboratory Operations and Applied Science. This system will replace outdated devices and support the development of methods for analyzing food contaminants, including polyfluoroalkyl substances (PFAS). The FDA seeks capability statements from small businesses and other suppliers, encouraging a competitive environment to explore potential solutions. Key requirements include the provision of new equipment, installation, training, and a one-year warranty on services. Responses must detail the responding organization’s qualifications, past performance, and delivery capabilities. The procurement aims to enhance the FDA's capacity in food safety analysis. Responses are due by July 24, 2025, and this notice serves as a preliminary step to assess interest before issuing a formal solicitation.